Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Chemfab Alkalis Limited (CHEMFAB.NS)
Chennai, IN
Established in 1985 and headquartered in Chennai, India, Chemfab Alkalis Limited is an international manufacturer and vendor of inorganic chemical products. The company's business activities are structured around two main segments: Chemicals and Related Products/Services, and PVC-O Pipes. Its comprehensive product range includes various chemicals like caustic soda (available in lye and flake forms), liquid chlorine, hydrogen gas, hydrochloric acid, and sodium hypochlorite/bleach liquor, in addition to industrial-grade and edible salt varieties. Formerly operating as Teamec Chlorates Limited, the company officially adopted its current name, Chemfab Alkalis Limited, in July 2017.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.52% | -2.46% | +5.02% | +6.69% | -18.85% | +0.70% | -50.78% | +45.28% | +153.91% | +66.03% | +66.03% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-7.0% Q1'26: -19.0% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+51.0% ★ Q1'26: +105.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-1.6% Q1'26: -87.3% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-0.4% Q1'26: +0.8% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-0.3% Q1'26: +0.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.8% Q1'26: -0.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×4.62× Q1'26: 3.69× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2020 actual |
Mar 2021 actual |
Mar 2024 actual |
Mar 2025 actual |
|---|---|---|---|---|
| Revenue |
2.04B
est: 2.31B (-11.7%)
|
1.81B
est: 2.66B (-32.1%)
|
3.27B
est: 2.28B (+43.6%)
|
3.34B
est: 2.62B (+27.6%)
|
| EBITDA |
554.94M
est: 479.29M (+15.8%)
|
250.16M
est: 540.32M (-53.7%)
|
632.53M
est: 472.21M (+34.0%)
|
444.34M
est: 543.04M (-18.2%)
|
| EBIT |
298.62M
est: 275.65M (+8.3%)
|
35.14M
est: 310.75M (-88.7%)
|
409.02M
est: 271.58M (+50.6%)
|
81.03M
est: 312.31M (-74.1%)
|
| Net Income |
254.46M
est: 339.52M (-25.1%)
|
-81.32M
est: 379.75M (-121.4%)
|
263.23M
est: 332.87M (-20.9%)
|
-69.40M
est: 374.14M (-118.6%)
|
| SGA |
35.81M
est: 161.11M (-77.8%)
|
185.27M
est: 181.63M (+2.0%)
|
236.26M
est: 158.73M (+48.8%)
|
255.05M
est: 182.54M (+39.7%)
|
| EPS |
18.37
est: 23.78 (-22.7%)
|
-5.81
est: 26.72 (-121.7%)
|
18.53
est: 23.31 (-20.5%)
|
-4.86
est: 26.20 (-118.5%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-15 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Suresh Krishnamurthi Rao | Founder & Non Independent Non Executive Chairman | 41M | male |
| Vaithamanithi Mudumbai Srinivasan | Chief Executive Officer | 18M | male |
| S. Prasath | Chief Financial Officer | 5M | male |
| Bharatraj Panchal | Company Secretary & Compliance Officer | — | male |
| V. R. Raguraman | Vice President of Administration | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CHEMFAB.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
